star-sportsmed.comCrawled Nov 10, 2026
The knotted PEEK suture anchor comes in 2.5mm and 3.0mm sizes with single- and double-loaded sutures and various handle options.
STAR Sports Medicine’s team at EFORT 2023 introduced products to surgeons and partners in Vienna, Austria.
On the second day of the congress, STAR Sports Medicine welcomed surgeons, partners, and their peers at their booth.
STAR Sports Medicine showcased sports medicine solutions at Africa Health ExCon 2023 in Egypt.
STAR Sports Medicine participated in CAOS 2023 at the Qingdao International Convention Center, Shandong, China.
Vienna, Austria – STAR Sports Medicine's booth welcomed more than 150 surgeons and partners at EFORT 2023 Congress with our advanced medical devices received ou...
Global Offering
STAR Sports Medicine is hiring a Sales Manager for the Latin America region.
STAR Sports Medicine manufactures sports medicine products, including titanium, PEEK, all-suture, and bio-absorbable solutions.
STAR Sports Medicine manufactures innovative sports medicine products and offers CFDA-approved clinical solutions.
(ix) PRC Company Law, PRC Securities Law and Overseas Listing Trial Measures with Unofficial English Translation
Star Sports Medicine Co. Ltd. (1609.HK) saw its shares triple from the IPO price upon trading debut on Tuesday, later settling up 132% at midday due to high demand. The oversubscribed offering highlights strong investor interest in the medical device company’s market entry. Trading activity reflects robust early-stage valuation growth for the firm.
May 2026Bamboo WorksNews article
Star Sports Medicine’s stock price surges by 118% following its Hong Kong stock exchange debut. The rally reflects broader investor enthusiasm for Chinese healthcare companies entering the market. Demand for healthcare listings remains strong amid renewed confidence in the sector.
May 2026The Business TimesNews article
Star Sports Medicine Co’s shares jumped **204%** during their Hong Kong Stock Exchange debut, continuing a trend of strong first-day trading performances in the city. The company manufactures medical devices and attracted significant investor interest at launch. The surge reflects heightened demand for healthcare-related stocks in Hong Kong’s market.
May 2026Yahoo FinanceNews article
Star Sports Medicine completes a **HKD 830 million IPO** on the Hong Kong Stock Exchange, issuing **8.4 million shares at HKD 98.5 each** to fund growth in China’s sports medicine device market. The company, a leading domestic manufacturer, secures capital to strengthen its position amid rising demand for sports injury solutions. The listing marks a key milestone for the firm’s expansion in Asia’s fastest-growing sports healthcare sector.
Apr 2026Insight, China's Pharmaceutical IndustryNews article